Comprehensive coverage

Biondwax

Prof. Natan Kerin, Faculty of Medicine at the Technion

Biotechnology cluster: Glaxo-Smith-Kline and Biorap signed an agreement to develop a drug to prevent transplant rejection and to treat autoimmune diseases

  • No comments
Dr. Ron Babkov CEO of Biondwax

Biondvax won an innovation award for the development of a universal flu vaccine

  • 3 תגובות
Science website logo
SEARCH